Naphazoline/zinc sulfate ophthalmic Interactions
There are 49 drugs known to interact with naphazoline/zinc sulfate ophthalmic, along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with naphazoline/zinc sulfate ophthalmic
- View naphazoline/zinc sulfate ophthalmic disease interactions (4)
Most frequently checked interactions
View interaction reports for naphazoline / zinc sulfate ophthalmic and the medicines listed below.
- Acular LS (ketorolac ophthalmic)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Aimovig (erenumab)
- Alcaine (proparacaine ophthalmic)
- Alocril (nedocromil ophthalmic)
- Alrex (loteprednol ophthalmic)
- Asmanex Twisthaler (mometasone)
- Augmentin (amoxicillin / clavulanate)
- Avastin (bevacizumab)
- Azasite (azithromycin ophthalmic)
- Azopt (brinzolamide ophthalmic)
- Betadine Ophthalmic Solution (povidone iodine ophthalmic)
- Betaxon (levobetaxolol ophthalmic)
- Betoptic (betaxolol ophthalmic)
- Betoptic Pilo (betaxolol / pilocarpine ophthalmic)
- Betoptic S (betaxolol ophthalmic)
- Botox (onabotulinumtoxinA)
- Celestone (betamethasone)
- Chromium GTF (chromium picolinate)
- Ciloxan (ciprofloxacin ophthalmic)
- CoQ10 (ubiquinone)
- Cyclogyl (cyclopentolate ophthalmic)
- Cymbalta (duloxetine)
- Diurex Max (pamabrom)
- Elidel (pimecrolimus topical)
- Nevanac (nepafenac ophthalmic)
- Restasis (cyclosporine ophthalmic)
- Travatan Z (travoprost ophthalmic)
- Voltaren Ophthalmic (diclofenac ophthalmic)
Naphazoline/zinc sulfate ophthalmic disease interactions
There are 4 disease interactions with naphazoline / zinc sulfate ophthalmic which include:
More about naphazoline / zinc sulfate ophthalmic
- naphazoline/zinc sulfate ophthalmic consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Drug class: ophthalmic antihistamines and decongestants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.